Cleavage-Resistant CYLD Protects Against Autoimmune Hepatitis

Using a concanavalin A-induced murine model of experimental autoimmune hepatitis, researchers identified proteolytic cleavage of the deubiquitinase cylindromatosis (CYLD) at Asp215 as a critical molecular event that promotes disease progression.